Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Perner

Showing results (231-240 of 283) with videos related to

Pageof 29
Sort By:
Cancer Research|February 18, 2010
An oncogenic role for ETV1 in melanomaJudit Jané-Valbuena, Hans R Widlund, Sven Perner, et al.
Genes, Chromosomes & Cancer|January 22, 2009
Distinct genomic aberrations associated with ERG rearranged prostate cancerFrancesca Demichelis, Sunita R Setlur, Rameen Beroukhim, et al.
Carcinogenesis|September 6, 2021
Analysis of tripartite motif (TRIM) family gene expression in prostate cancer bone metastasesAnne Offermann, Duan Kang, Christian Watermann, et al.
BMC Medical Genomics|March 18, 2010
Molecular sampling of prostate cancer: a dilemma for predicting disease progressionAndrea Sboner, Francesca Demichelis, Stefano Calza, et al.
International Journal of Molecular Sciences|December 11, 2022
Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate CancerGunhild von Amsberg, Mirjam Zilles, Wael Mansour, et al.
Translational Lung Cancer Research|July 18, 2020
Lung cancer biomarker testing: perspective from EuropeErik Thunnissen, Birgit Weynand, Dalma Udovicic-Gagula, et al.
Oncotarget|February 2, 2017
MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapySimon Laban, Gregor Giebel, Niklas Klümper, et al.
International Journal of Cancer|February 3, 2023
Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapyDaria Klusa, Fabian Lohaus, Andre Franken, et al.
Molecular Cancer|June 18, 2022
Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancerIsabel Heidegger, Georgios Fotakis, Anne Offermann, et al.
Nature Structural & Molecular Biology|January 12, 2016
Assembly of methylated KDM1A and CHD1 drives androgen receptor-dependent transcription and translocationEric Metzger, Dominica Willmann, Joel McMillan, et al.
Pageof 29

Showing results (231-240 of 283) with videos related to

Sort By:
Pageof 29
Cancer Research|February 18, 2010
An oncogenic role for ETV1 in melanomaJudit Jané-Valbuena, Hans R Widlund, Sven Perner, et al.
Genes, Chromosomes & Cancer|January 22, 2009
Distinct genomic aberrations associated with ERG rearranged prostate cancerFrancesca Demichelis, Sunita R Setlur, Rameen Beroukhim, et al.
Carcinogenesis|September 6, 2021
Analysis of tripartite motif (TRIM) family gene expression in prostate cancer bone metastasesAnne Offermann, Duan Kang, Christian Watermann, et al.
BMC Medical Genomics|March 18, 2010
Molecular sampling of prostate cancer: a dilemma for predicting disease progressionAndrea Sboner, Francesca Demichelis, Stefano Calza, et al.
International Journal of Molecular Sciences|December 11, 2022
Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate CancerGunhild von Amsberg, Mirjam Zilles, Wael Mansour, et al.
Translational Lung Cancer Research|July 18, 2020
Lung cancer biomarker testing: perspective from EuropeErik Thunnissen, Birgit Weynand, Dalma Udovicic-Gagula, et al.
Oncotarget|February 2, 2017
MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapySimon Laban, Gregor Giebel, Niklas Klümper, et al.
International Journal of Cancer|February 3, 2023
Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapyDaria Klusa, Fabian Lohaus, Andre Franken, et al.
Molecular Cancer|June 18, 2022
Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancerIsabel Heidegger, Georgios Fotakis, Anne Offermann, et al.
Nature Structural & Molecular Biology|January 12, 2016
Assembly of methylated KDM1A and CHD1 drives androgen receptor-dependent transcription and translocationEric Metzger, Dominica Willmann, Joel McMillan, et al.
Pageof 29